Comprehensive Analysis of the Expression and Prognostic Significance of NPAS1 in Patients with Colorectal Adenocarcinoma Based on Bioinformatics.
1/5 보강
[BACKGROUND] Neuronal PAS domain protein 1 (NPAS1) is a protein-coding gene expressed mainly in the central nervous system and plays a key role in nervous system development.
APA
Bai M, Hu K, et al. (2026). Comprehensive Analysis of the Expression and Prognostic Significance of NPAS1 in Patients with Colorectal Adenocarcinoma Based on Bioinformatics.. International journal of general medicine, 19, 556875. https://doi.org/10.2147/IJGM.S556875
MLA
Bai M, et al.. "Comprehensive Analysis of the Expression and Prognostic Significance of NPAS1 in Patients with Colorectal Adenocarcinoma Based on Bioinformatics.." International journal of general medicine, vol. 19, 2026, pp. 556875.
PMID
41773256 ↗
Abstract 한글 요약
[BACKGROUND] Neuronal PAS domain protein 1 (NPAS1) is a protein-coding gene expressed mainly in the central nervous system and plays a key role in nervous system development. The expression and prognostic value of NPAS1 in colorectal adenocarcinoma (COAD) are unknown.
[METHODS] The expression and clinicopathological data of COAD from Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were analyzed. NPAS1 gene expression in colon cancer tissues was validated by Western blotting and immunohistochemical staining. Function and immune infiltration were established using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and single sample Gene Set Enrichment Analysis (ssGSEA). Methylation levels were analyzed utilizing the UALCAN database. NPAS1-related mutations were analyzed using cBioPortal. Single-cell and tissue-specific expression of NPAS1 was examined using the Human Protein Atlas. Protein-protein interactions and transcription factor networks of NPAS1-associated genes were analyzed with STRING and Network Analyst.
[RESULTS] Our study found that the expression level of NPAS1 was higher in normal tissues compared to COAD tissues, higher NPAS1 expression was associated with better survival outcomes. The bioinformatics analysis confirmed that NPAS1 co-expressed genes were linked to diverse signalling pathways and cellular functions. NPAS1 is correlated with CD56bright, cytotoxic and NK cells, and negatively correlated with helper T cells and Tcm cells. The DNA methylation level of NPAS1 in tumor tissues was elevated compared to normal tissues. We analyzed the mutation characteristics of NPAS1, single-cell expression profiling of NPAS1, and protein-protein interactions involving genes associated with NPAS1. These discoveries offered perspectives on the etiology, identification, and management of COAD.
[CONCLUSION] This study revealed a significant decrease of NPAS1 expression in COAD tissues, exhibiting associations with the clinical stage, prognosis, immune infiltration, and DNA methylation of COAD.
[METHODS] The expression and clinicopathological data of COAD from Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were analyzed. NPAS1 gene expression in colon cancer tissues was validated by Western blotting and immunohistochemical staining. Function and immune infiltration were established using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and single sample Gene Set Enrichment Analysis (ssGSEA). Methylation levels were analyzed utilizing the UALCAN database. NPAS1-related mutations were analyzed using cBioPortal. Single-cell and tissue-specific expression of NPAS1 was examined using the Human Protein Atlas. Protein-protein interactions and transcription factor networks of NPAS1-associated genes were analyzed with STRING and Network Analyst.
[RESULTS] Our study found that the expression level of NPAS1 was higher in normal tissues compared to COAD tissues, higher NPAS1 expression was associated with better survival outcomes. The bioinformatics analysis confirmed that NPAS1 co-expressed genes were linked to diverse signalling pathways and cellular functions. NPAS1 is correlated with CD56bright, cytotoxic and NK cells, and negatively correlated with helper T cells and Tcm cells. The DNA methylation level of NPAS1 in tumor tissues was elevated compared to normal tissues. We analyzed the mutation characteristics of NPAS1, single-cell expression profiling of NPAS1, and protein-protein interactions involving genes associated with NPAS1. These discoveries offered perspectives on the etiology, identification, and management of COAD.
[CONCLUSION] This study revealed a significant decrease of NPAS1 expression in COAD tissues, exhibiting associations with the clinical stage, prognosis, immune infiltration, and DNA methylation of COAD.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- ROCK1 inhibition primes anti-tumor immunity in EGFR-mutant NSCLC by triggering PD-L1 degradation mediated by SMURF2.
- Identification of altered immune landscape at single-cell resolution in NSCLC brain metastasis and its association with poor immune checkpoint inhibitor responses.
- An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study.
- A Polysaccharide-Based Fluorescent Polymer Carrier for Natural Product Delivery and Gastric Cancer Inhibition.
- Lung cancer and COVID-19 susceptibility and severity: a Mendelian randomization analysis.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.
- Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.
- Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.
- BioLM-NET: an interpretable deep learning model combining prior biological knowledge and contextual LLM gene embeddings on multi-omics data to predict disease.
- Folate Intake and Breast Cancer Risk: A Systematic Review and Meta-Analysis.
- Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulators.